Literature DB >> 12882725

Treatment response to conventional and novel therapies in chronic prostatitis.

Daniel A Shoskes1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882725     DOI: 10.1007/s11934-003-0091-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


× No keyword cloud information.
  49 in total

Review 1.  Bioavailability and health effects of dietary flavonols in man.

Authors:  P C Hollman; M B Katan
Journal:  Arch Toxicol Suppl       Date:  1998

Review 2.  Mycoplasma genitalium -- an up-date.

Authors:  David Taylor-Robinson
Journal:  Int J STD AIDS       Date:  2002-03       Impact factor: 1.359

3.  Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response.

Authors:  A R Shahed; D A Shoskes
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

4.  Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia.

Authors:  E W Rugendorff; W Weidner; L Ebeling; A C Buck
Journal:  Br J Urol       Date:  1993-04

5.  Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate.

Authors:  T Goto; S Makinose; Y Ohi; D Yamauchi; T Kayajima; K Nagayama; H Hayami
Journal:  Int J Urol       Date:  1998-05       Impact factor: 3.369

6.  Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis.

Authors:  D A Shoskes; S I Zeitlin
Journal:  Prostate Cancer Prostatic Dis       Date:  1999-05       Impact factor: 5.554

7.  Validity and responsiveness of the national institutes of health chronic prostatitis symptom index.

Authors:  Judith A Turner; Marcia A Ciol; Michael Von Korff; Richard Berger
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

8.  Use of terazosin in prostatodynia and validation of a symptom score questionnaire.

Authors:  D E Neal; T D Moon
Journal:  Urology       Date:  1994-04       Impact factor: 2.649

9.  Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities.

Authors:  J J de la Rosette; H F Karthaus; P E van Kerrebroeck; T de Boo; F M Debruyne
Journal:  Eur Urol       Date:  1992       Impact factor: 20.096

10.  Use of a novel non-steroidal anti-inflammatory drug, nimesulide, in the treatment of abacterial prostatovesiculitis.

Authors:  D Canale; I Scaricabarozzi; P Giorgi; P Turchi; M Ducci; G F Menchini-Fabris
Journal:  Andrologia       Date:  1993 May-Jun       Impact factor: 2.775

View more
  3 in total

Review 1.  Sexual dysfunction and prostatitis.

Authors:  Hossein Sadeghi-Nejad; Allen Seftel
Journal:  Curr Urol Rep       Date:  2006-11       Impact factor: 2.862

2.  Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Disease or Symptom? Current Perspectives on Diagnosis, Treatment, and Prognosis.

Authors:  Jianzhong Zhang; ChaoZhao Liang; Xuejun Shang; Hongjun Li
Journal:  Am J Mens Health       Date:  2020 Jan-Feb

3.  Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways.

Authors:  Ashley B Ward; Hina Mir; Neeraj Kapur; Dominique N Gales; Patrick P Carriere; Shailesh Singh
Journal:  World J Surg Oncol       Date:  2018-06-14       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.